Climb Bio, Inc.
CLYM
$16.33
$1.6010.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -55.76% | 33.97% | -108.13% | -44.89% | 84.21% |
| Total Depreciation and Amortization | -13.16% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 119.55% | -2.61% | -52.25% | 32.18% | -99.06% |
| Change in Net Operating Assets | 161.14% | -152.76% | -24.22% | -112.18% | -252.07% |
| Cash from Operations | 5.40% | 6.84% | -183.19% | -60.68% | -1,571.36% |
| Capital Expenditure | -237.66% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,272.18% | 69.70% | 147.82% | 121.41% | 197.26% |
| Cash from Investing | -1,296.47% | 69.70% | 147.82% | 121.26% | 149.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -77.66% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 65.60% | -- | -- |
| Cash from Financing | -- | -- | -151.22% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 26.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 666.33% | 53.05% | 116.76% | 104.06% | -105.37% |